Table 11C: Change in NVA in total number of patients on follow-up

Route		1 week prior		At 1st week presence		p-value		Significance		At 4th week presence		p-value		Significance
Intracameral		4		0		0.04		S		0		0.04		S
Intravitreal		3		0		0.03		S		0		0.03		S
Combined		2		0		0.04		S		0		0.04		S
S: Significant
Route		1 week prior		At 8th week presence		p-value		Significance		At 12th week presence		p-value		Significance
Intracameral		4		2		0.16		NS		4		–		NS
Intravitreal		3		1		0.08		NS		2		0.15		NS
Combined		2		0		0.04		S		1		0.31		NS

NS: Not significant; S: Significant